ARTICLE | Company News
Inception 4 Inc., Inception Sciences, Bayer ophthalmic news
November 25, 2013 8:00 AM UTC
Bayer's Bayer HealthCare AG unit, Versant Ventures and drug discovery company Inception Sciences launched Inception 4 to conduct early research to develop treatments for ophthalmic disorders. Versant will provide equity financing, and Bayer will provide undisclosed milestone-based funding. ...